BioMed Realty Trust Inc. (NYSE: BMR) reported Q1 FFO of $0.29, $0.01 worse than the analyst estimate of $0.30. Revenue for the quarter came in at $105.5 million versus the consensus estimate of $106.01 million.

Earnings